Detailed answers about WILLIAMSON BIOTECH SOLUTIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was WILLIAMSON BIOTECH SOLUTIONS LIMITED founded?
WILLIAMSON BIOTECH SOLUTIONS LIMITED was officially incorporated on 12 May 2016 and is registered under company number 10175635. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is WILLIAMSON BIOTECH SOLUTIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of WILLIAMSON BIOTECH SOLUTIONS LIMITED?
WILLIAMSON BIOTECH SOLUTIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does WILLIAMSON BIOTECH SOLUTIONS LIMITED do?
WILLIAMSON BIOTECH SOLUTIONS LIMITED operates in the following sectors: 70229 - Management consultancy activities other than financial management, 74909 - Other professional, scientific and technical activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is WILLIAMSON BIOTECH SOLUTIONS LIMITED's registered address?
The registered office address of WILLIAMSON BIOTECH SOLUTIONS LIMITED is 67 CHESSEL AVENUE, SOUTHAMPTON, HAMPSHIRE, UNITED KINGDOM, SO19 4DY. This is the official address filed with Companies House for legal and statutory correspondence.
Is WILLIAMSON BIOTECH SOLUTIONS LIMITED financially stable?
The most recent accounts for WILLIAMSON BIOTECH SOLUTIONS LIMITED were made up to 31 May 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 28 February 2027.